Skip Nav Destination
Article navigation
Meeting Abstracts|
September 1987
PHARMACOLOGICAL QUANTITATION OF MIDAZOLAM'S CNS DRUG EFFECT IN HYPNOTIC DOSES
Stanford University Medical School, Department of Anesthesiology, Stanford, Ca 94305, and the Veterans Administration Medical Center, Palo Alto, Ca 94304.
Anesthesiology September 1987, Vol. 67, A658.
Citation
M. Bührer, P. O. Maitre, W. F. Ebling, D. R. Stanski; PHARMACOLOGICAL QUANTITATION OF MIDAZOLAM'S CNS DRUG EFFECT IN HYPNOTIC DOSES. Anesthesiology 1987; 67:A658 doi: https://doi.org/10.1097/00000542-198709001-00658
Download citation file:
Citing articles via
Most Viewed
Related Articles
Population Pharmacokinetics of Midazolam Administered by Target Controlled Infusion for Sedation following Coronary Artery Bypass Grafting
Anesthesiology (December 1998)
Modifying Methoxycarbonyl Etomidate Inter-Ester Spacer Optimizes In Vitro Metabolic Stability and In Vivo Hypnotic Potency and Duration of Action
Anesthesiology (November 2012)
Electroencephalographic Recovery, Hypnotic Emergence, and the Effects of Metabolite after Continuous Infusions of a Rapidly Metabolized Etomidate Analog in Rats
Anesthesiology (May 2012)
Effect of N -methyl-d-aspartate Receptor ε 1 Subunit Gene Disruption of the Action of General Anesthetic Drugs in Mice
Anesthesiology (March 2005)
Clinical and Molecular Pharmacology of Etomidate
Anesthesiology (March 2011)
